中医药治疗腹膜透析致腹膜纤维化研究进展  

Research Progress of Traditional Chinese Medicine on Peritoneal Fibrosis Induced by Peritoneal Dialysis

作　　者：赵庆云 吴乃超 杨洪涛[1] ZHAO Qingyun;WU Naichao;YANG Hongtao(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300387,China;Second Hospital of Jilin University,Changchun 130000,Jilin,China)

机构地区：[1]天津中医药大学第一附属医院,天津300387 [2]吉林大学第二医院,吉林长春130000

出　　处：《辽宁中医药大学学报》2019年第12期93-95,共3页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：国家自然科学基金资助项目（81373851;81873263）

摘　　要：腹膜透析是终末期肾病重要的肾脏替代治疗方法之一,但往往由于腹膜透析导致的腹膜纤维化致使腹膜超滤量降低,最终不得不停止腹膜透析,大量相关研究在探索防治腹膜纤维化的防治方法。该文将从中医药治疗腹膜透析致腹膜纤维化的研究进展角度,从单味中药及复方中药两个方面综述近年来对于腹膜纤维化防治的探索,并概括当前现状及缺陷,指明未来研究方向,为相关研究者提供参考。Peritoneal dialysis is one of the important kidney replacement treatments of end-stage kidney diseases. However,the peritoneal fibrosis induced by peritoneal dialysis usually leads to a decrease in peritoneal ultrafiltration,which stop peritoneal dialysis. A large number of related studies are exploring the prevention and treatment of the peritoneal fibrosis. In this paper,the author review the research on the prevention and treatment of single and compound Chinese medicine on peritoneal fibrosis in recent years from the perspective of traditional Chinese medicine treatment on peritoneal fibrosis induced by peritoneal dialysis,summarize the current status and defects,indicate the future research direction and provide references for relevant researchers.

关 键 词：腹膜透析 腹膜纤维化 单味中药 复方中药 

分 类 号：R692[医药卫生—泌尿科学]